What does CUSIP 45166A102 represent in this 13F holders report?

CUSIP 45166A102 is the security identifier for IDYA - IDEAYA Biosciences, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held IDYA - IDEAYA Biosciences, Inc. - Common Stock in Q1 2023?

127 institutional investors reported IDYA - IDEAYA Biosciences, Inc. - Common Stock for Q1 2023. Use the holders table for investor-level position and value details.

IDEAYA Biosciences, Inc. - Common Stock (IDYA)

CUSIP: 45166A102

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class: Equity / Common Stock
Shares outstanding: 87,836,000
Total 13F shares: 45,571,754
Share change: -398,811
Total reported value: $625,396,958
Put/Call ratio: 0%
Price per share: $13.73
Number of holders: 127
Value change: -$7,022,953
Number of buys: 74
Number of sells: 41

Quarterly Holders Quick Answers

What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2023
Previous quarter: Q4 2022

Recent filing periods for CUSIP 45166A102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Logos Global Management LP	13F	Company	4.4%	3,900,000	$70,863,000	—	31 Dec 2022	13F
Avidity Partners Management LP	13F	Company	4.4%	3,824,800	$69,496,616	—	31 Dec 2022	13F
BlackRock Finance, Inc.	13F	Company	4%	3,536,730	$64,262,384	—	31 Dec 2022	13F
FEDERATED HERMES, INC.	13F	Company	3.3%	2,864,500	$52,047,965	—	31 Dec 2022	13F
Canaan Partners X LLC	13F	Company	3%	2,660,713	$48,345,155	—	31 Dec 2022	13F
STATE STREET CORP	13F	Company	2.6%	2,322,641	$42,202,387	—	31 Dec 2022	13F
VANGUARD GROUP INC	13F	Company	2.6%	2,289,802	$41,605,703	—	31 Dec 2022	13F
BVF INC/IL	13F	Company	2.5%	2,205,089	$40,066,467	—	31 Dec 2022	13F
Boxer Capital, LLC	13F	Company	2.5%	2,202,812	$40,025,094	—	31 Dec 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	2.5%	2,201,559	$40,002,327	—	31 Dec 2022	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	2%	1,743,628	$31,681,721	—	31 Dec 2022	13F
BAKER BROS. ADVISORS LP	13F	Company	1.9%	1,668,355	$30,314,010	—	31 Dec 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.9%	1,663,528	$30,226,000	—	31 Dec 2022	13F
5AM Venture Management, LLC	13F	Company	1.4%	1,196,298	$21,736,735	—	31 Dec 2022	13F
CITADEL ADVISORS LLC	13F	Company	1%	886,859	$16,114,228	—	31 Dec 2022	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.95%	830,537	$15,090,857	—	31 Dec 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.92%	805,901	$14,643,000	—	31 Dec 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.83%	727,316	$13,215,000	—	31 Dec 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.78%	683,977	$12,434,700	—	31 Dec 2022	13F
FMR LLC	13F	Company	0.63%	557,150	$10,123,416	—	31 Dec 2022	13F
Sofinnova Investments, Inc.	13F	Company	0.54%	474,530	$8,622,210	—	31 Dec 2022	13F
DAFNA Capital Management LLC	13F	Company	0.53%	468,358	$8,510,065	—	31 Dec 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.48%	418,989	$7,613,000	—	31 Dec 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.47%	410,570	$7,460,000	—	31 Dec 2022	13F
NORTHERN TRUST CORP	13F	Company	0.46%	404,329	$7,346,658	—	31 Dec 2022	13F
Cormorant Asset Management, LP	13F	Company	0.4%	350,000	$6,360,000	—	31 Dec 2022	13F
AXA S.A.	13F	Company	0.39%	340,969	$6,195,407	—	31 Dec 2022	13F
S.c.a. Candriam	13F	Individual	0.32%	280,317	$5,093,121	—	31 Dec 2022	13F
Nantahala Capital Management, LLC	13F	Company	0.29%	253,480	$4,605,732	—	31 Dec 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.21%	186,427	$3,387,000	—	31 Dec 2022	13F
Michael P. Dillon	3/4/5	SVP, Chief Scientific Officer	— mixed-class rows	102,226 mixed-class rows	$3,311,116	—	04 Oct 2021	3/4/5
BANK OF AMERICA CORP /DE/	13F	Company	0.19%	170,136	$3,091,371	—	31 Dec 2022	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.19%	165,200	$3,001,684	—	31 Dec 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.18%	160,831	$2,922,299	—	31 Dec 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.18%	154,263	$2,802,959	—	31 Dec 2022	13F
Bank of New York Mellon Corp	13F	Company	0.17%	152,613	$2,772,978	—	31 Dec 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.16%	139,963	$2,543,128	—	31 Dec 2022	13F
Opaleye Management Inc.	13F	Company	0.16%	138,800	$2,521,996	—	31 Dec 2022	13F
NORGES BANK	13F	Company	0.16%	137,500	$2,498,375	—	31 Dec 2022	13F
Tekla Capital Management LLC	13F	Company	0.15%	133,185	$2,419,971	—	31 Dec 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.14%	125,600	$2,282,152	—	31 Dec 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.13%	118,138	$2,146,567	—	31 Dec 2022	13F
UBS Group AG	13F	Company	0.13%	114,603	$2,082,337	—	31 Dec 2022	13F
Invesco Ltd.	13F	Company	0.12%	109,153	$1,983,310	—	31 Dec 2022	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.12%	109,000	$1,980,530	—	31 Dec 2022	13F
BARCLAYS PLC	13F	Company	0.11%	94,343	$1,714,212	—	31 Dec 2022	13F
Swiss National Bank	13F	Company	0.11%	92,800	$1,686,176	—	31 Dec 2022	13F
Ensign Peak Advisors, Inc	13F	Company	0.11%	92,411	$1,679,108	—	31 Dec 2022	13F
Ghisallo Capital Management LLC	13F	Company	0.1%	87,500	$1,589,875	—	31 Dec 2022	13F
CITIGROUP INC	13F	Company	0.08%	70,137	$1,274,389	—	31 Dec 2022	13F

Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q1 2023

As of 31 Mar 2023, IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,571,754 shares. The largest 10 holders included Avidity Partners Management LP, Logos Global Management LP, BlackRock Inc., FEDERATED HERMES, INC., ADAGE CAPITAL PARTNERS GP, L.L.C., Canaan Partners X LLC, BVF INC/IL, VANGUARD GROUP INC, Boxer Capital, LLC, and STATE STREET CORP. This page lists 127 institutional shareholders reporting positions in this security for the Q1 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 holders

117

Q1 2023 holders

127

Holder diff

Investor	Q4 2022 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q4 2022 Value $	Q1 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.